HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Shunji Sano Nobuyoshi Shimizu Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Date, H. Articles by Shimizu, N. Search for Related Content PubMed PubMed Citation Articles by Date, H. Articles by Shimizu, N. Related Collections Lung - transplantation

J Thorac Cardiovasc Surg 2004;128:933-940
© 2004 The American Association for Thoracic Surgery

Cardiothoracic Transplantation

Improved survival after living-donor lobar lung transplantation

^a Department of Cancer and Thoracic Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
^b Department of Cardiology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
^c Department of Anesthesiology and Resuscitology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
^d Department of Cardiovascular Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan

Received for publication April 17, 2004; revisions received July 19, 2004; accepted for publication July 23, 2004.

^* Address for reprints: Hiroshi Date, MD, Department of Cancer and Thoracic Surgery (Surgery II), Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-Cho, Okayama 700-8558, Japan (E-mail: hdate{at}nigeka2.hospital.okayama-u.ac.jp).

OBJECTIVE: Survival after living-donor lobar lung transplantation has been reported to be similar to that after cadaveric lung transplantation. The purpose of this study was to summarize our 5-year experience of living-donor lobar lung transplantation for critically ill patients.

METHODS: Between October 1998 and April 2004, we performed living-donor lobar lung transplantation in 30 critically ill patients with various lung diseases, including 5 (17%) patients on a ventilator. Mean age was 30.4 years (range, 8-55 years). Postoperative management included slow weaning from a ventilator, relatively low-dose immunosuppressants, and careful rejection monitoring on the basis of radiographic and clinical findings without transbronchial lung biopsy.

RESULTS: The average duration of mechanical ventilation was 15.4 days, intensive care unit stay was 23.5 days, and hospital stay was 64.6 days. Clinically judged acute rejection occurred at an average rate of 1.5 episodes per patient, but infection occurred in only one patient during the first month. In spite of the complicated postoperative course, all patients were discharged without oxygen inhalation. Four patients had unilateral bronchiolitis obliterans syndrome, but the decrease in their forced expiratory volume in 1 second values stopped within 9 months. All 30 recipients are currently alive, with a follow-up period of 1 to 66 months. All donors have returned to their previous lifestyles.

CONCLUSIONS: Living-donor lobar lung transplantation can be applied to both pediatric and adult patients with very limited life expectancies. It might provide better survival than conventional cadaveric lung transplantation.

This article has been cited by other articles:

				S. C. Sweet Pediatric Lung Transplantation Proceedings of the ATS, January 15, 2009; 6(1): 122 - 127. [Abstract] [Full Text] [PDF]

				F. Venuta and M. Anile Invited commentary. Ann. Thorac. Surg., October 1, 2008; 86(4): 1129 - 1130. [Full Text] [PDF]

				H. Date, K. F. Kusano, H. Matsubara, A. Ogawa, H. Fujio, K. Miyaji, M. Okazaki, M. Yamane, S. Toyooka, M. Aoe, et al. Living-Donor Lobar Lung Transplantation for Pulmonary Arterial Hypertension After Failure of Epoprostenol Therapy J. Am. Coll. Cardiol., August 7, 2007; 50(6): 523 - 527. [Abstract] [Full Text] [PDF]

				S. Sugimoto, H. Date, R. Sugimoto, M. Aoe, and Y. Sano Bilateral native lung-sparing lobar transplantation in a canine model. J. Thorac. Cardiovasc. Surg., November 1, 2006; 132(5): 1213 - 1218. [Abstract] [Full Text] [PDF]

				K. Aokage, H. Date, R. Sugimoto, M. Okazaki, D. Okutani, H. Inokawa, M. Aoe, and N. Shimizu A canine experimental study to assess the potential of unilateral double lobar lung transplantation Eur. J. Cardiothorac. Surg., January 1, 2006; 29(1): 40 - 44. [Abstract] [Full Text] [PDF]

				S. Sugimoto, H. Date, R. Sugimoto, M. Okazaki, M. Aoe, Y. Sano, and N. Shimizu Thoracoscopic operation with local and epidural anesthesia in the treatment of pneumothorax after lung transplantation J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1219 - 1220. [Full Text] [PDF]

				H. Date, Y. Tanimoto, K. Goto, I. Yamadori, M. Aoe, Y. Sano, and N. Shimizu A New Treatment Strategy for Advanced Idiopathic Interstitial Pneumonia*: Living-Donor Lobar Lung Transplantation Chest, September 1, 2005; 128(3): 1364 - 1370. [Abstract] [Full Text] [PDF]

				H. Date, M. Aoe, Y. Sano, K. Goto, M. Kawada, and N. Shimizu Bilateral living-donor lobar lung transplantation MMCTS, August 9, 2005; 2005(0809): 976. [Abstract] [Full Text] [PDF]